Capricor Therapeutics
CAPR
#7991
Rank
โ‚น26.09 B
Marketcap
โ‚น570.82
Share price
-4.36%
Change (1 day)
-54.77%
Change (1 year)

Capricor Therapeutics (CAPR) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น8.84 Billion

According to Capricor Therapeutics 's latest financial reports the company has โ‚น8.84 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Capricor Therapeutics - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น12.99 B295.4%
2023-12-31โ‚น3.28 B-4.09%
2022-12-31โ‚น3.42 B32.01%
2021-12-31โ‚น2.59 B8.69%
2020-12-31โ‚น2.38 B238.89%
2019-12-31โ‚น0.70 B38.93%
2018-12-31โ‚น0.50 B-43.74%
2017-12-31โ‚น0.90 B-18.05%
2016-12-31โ‚น1.10 B22.06%
2015-12-31โ‚น0.90 B77.06%
2014-12-31โ‚น0.50 B300.9%
2013-12-31โ‚น0.12 B-46.83%
2012-12-31โ‚น0.23 B334.54%
2011-12-31โ‚น54.97 M-63.68%
2010-12-31โ‚น0.15 B2.73%
2009-12-31โ‚น0.14 B-44.27%
2008-12-31โ‚น0.26 B-58.5%
2007-12-31โ‚น0.63 B
2005-12-31โ‚น0.01 M-54.02%
2004-12-31โ‚น0.02 M-44.02%
2003-12-31โ‚น0.04 M3997.79%
2002-12-31โ‚น0 M-84.07%
2001-12-31โ‚น0 M-98.78%
2000-12-31โ‚น0.61 M
1999-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cytokinetics
CYTK
โ‚น86.38 B 876.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚น0.22 B-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.665 T 18,732.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น100.05 B 1,031.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น52.34 B 491.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.27 B-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA